PIMAVANSERIN (has an active metabolite) 
| PIMAVANSERIN | ATC N05AX17
NERVOUS SYSTEM ANTIPSYCHOTIC TREATMENT OF HALLUCINATIONS AND DELUSIONS ASSOCIATED WITH PARKINSON'S DISEASE PSYCHOSIS INVERSE AGONIST / ANTAGONIST SEROTONIN 5-HT2A (KI = 0.087 NANOMOLAR) AND 5-HT2C (KI = 0.44 NANOMOLAR) SIGMA 1 RECEPTOR (KI = 120 NANOMOLAR) | ORAL | Tmax 6 HOUR VD 2173 LITER PPB 95 PERCENT HT 57 HOUR SOLUBILITY SOLUBLE IN WATER | 5-HT2A RECEPTOR 5-HT2C RECEPTOR PDB 8ZMG (CRYSTAL STRUCTURE OF AN INVERSE AGONIST ANTIPSYCHOTIC DRUG PIMAVANSERIN-BOUND 5-HT2A) LIGAND CODE = A1L11 (link to the list of PDB complexes) Download experimental 3D coordinates of A1L11 with added hydrogens | 5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |